Public Company News

Hanwha Solutions acquires part of Samsung Electro-Mechanics' wireless module business

* The deal is designed to purchase Samsung Electro-Mechanics' business unit manufacturing Wi-Fi and 5G mmWave antenna modules with organic substrate. * With advanced communication modules for seamless Wi-Fi and 5G connections, Hanwha Solutions aims to expand its electronics business into wirel...

2022-01-05 00:45 2468

TCL Unveils Portable, Lightweight and Personal NXTWEAR AIR Wearable Display Glasses at CES 2022

LAS VEGAS, Jan. 4, 2022 /PRNewswire/ -- TCL , a leader in display technology and affordable, rich connected experiences, announces its second-generation wearable display glasses, NXTWEAR AIR. The new, stylish glasses combine exceptional display technology and ri...

2022-01-04 23:00 3130

TCL Provides Enriched Educational Experiences for All at CES 2022, Including the Company's First Windows Laptop

LAS VEGAS, Jan. 4, 2022 /PRNewswire/ -- TCL Communication , a pioneer of display technologies and affordable, premium smart experiences, demonstrates its commitment to providing enriched learning solutions for all with a range of new produc...

2022-01-04 22:30 3062

Origin Agritech Announces Collaboration with BaoDao Feed Ltd. To Commercialize Nutrition Enhanced Corn

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it has signed a collaborative agreement with BaoDao Feed Ltd. ("BaoDao"), a Chinese feed producer with500 million RMB in annual sales. U...

2022-01-04 22:10 2128

TCL To Release its First 144Hz Mini LED TV Series in 2022, Raising the Bar for Responsive Video Gaming on Large Screen TVs

HONG KONG, Jan. 4, 2022 /PRNewswire/ -- TCL Electronics (1070.HK), a leading consumer electronics brand, announced during CES 2022 that it will roll out 144Hz Mini LED TVs in 2022 to deliver a more responsive and fluid video gaming experience. The first of a new generation of TV displays, the TCL...

2022-01-04 22:00 4823

TCL Announces New Brand Slogan, 144 Hz Mini LED TVs & All-New Mobile Devices at CES 2022

HONG KONG, Jan. 4, 2022 /PRNewswire/ -- TCL Electronics (1070.HK), a leading consumer electronics brand, held a series of virtual press events today, where its chairperson and senior executives shared the company's latest brand slogan "Inspire Greatness" and business developments. The audience wa...

2022-01-04 22:00 5346

TCL Continues Commitment to Providing 5G For All with TCL 30 Series Launch at CES 2022

LAS VEGAS, Jan. 4, 2022 /PRNewswire/ -- TCL Communication, a pioneer in display technology and affordable, rich connected experiences, is announcing multiple 5G products at CES 2022 and beyond. These announcements enhance its vision of...

2022-01-04 22:00 2664

IT Tech Packaging, Inc. Releases 2022 Chairman Letter

BAODING, China, Jan. 4, 2022 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or "the Company"), a leading manufacturer and distributor of diversified paper products inNorth China, today released a letter to shareholders from the Chairman of the Company's board of...

2022-01-04 21:30 3923

IMTE to divest its Lamination Glass operation in China

SYDNEY, Jan. 4, 2022 /PRNewswire/ -- Integrated Media Technology Limited ("IMTE" or "Company") (Nasdaq:IMTE), informs that today its Board of Directors approved a plan to divest itsChina lamination glass operation.  IMTE intends to divest from its China electronic glass business by either sel...

2022-01-04 21:26 3977

ReTo Eco-Solutions, Inc. Enters into an Equity Acquisition Agreement to Acquire Solution and Product Provider of Internet of Things

BEIJING, Jan. 4, 2022 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (NASDAQ: RETO) ("ReTo" or the "Company"), a provider of technology solutions for the improvement of ecological environments, today announced that, its subsidiary, ReTo Technology Development Co., Ltd., entered into an Equity Acquisiti...

2022-01-04 21:00 3929

AirNet Announces Change of Auditor

BEIJING, Jan. 4, 2022 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), an in-flight solution provider on connectivity, entertainment, and digital multimedia inChina , today announced the appointment of Audit Alliance LLP ("Au...

2022-01-04 21:00 4466

Ubiik Selects Sequans Monarch 2 GM02S Module for Taiwan Power Company's Advanced Metering Infrastructure Deployment

PARIS, Jan. 4, 2022 /PRNewswire/ -- Sequans Communications S.A. (NYSE: SQNS) announced that Ubiik, a leading global Industrial IoT solutions provider with a proven track record in large scale deployments, is using its Monarch 2 GM02S LTE-M/NB-IoT module as a new connectivity solution in Ubiik's r...

2022-01-04 21:00 3586

Zepp Health To Host Wearables Data in Healthcare State-of-the-Union Event with Industry Thought Leaders on January 5, 2022

CUPERTINO, Calif., Jan. 4, 2022 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP)  today announced that it will host an event to share thoughts among industry leaders on the current state and path forward in the use of data in healthcare from smart wearable devices.  Speakers will include: * Zepp ...

2022-01-04 20:00 2373

Quectel Launches New Generation of Flagship Android Smart Module

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Quectel Wireless Solutions, a global supplier of IoT solutions, has announced the launch of the SG865W-WF, a new generation of flagship Android smart module. The module is equipped with Qualcomm's QCS8250 system-on-chip (SoC), which offers powerful performan...

2022-01-04 20:00 4340

Ring in the New Year with "Utano Princesama Shining Live" Campaigns

TOKYO, Jan. 4, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, together with BROCCOLI Co., Ltd., announced that its smartphone rhythm game Utano Princesama Shining Livecelebrated the new year with the start of the New Year's 2022 Campaign. Players can enjoy the New Year's campaign...

2022-01-04 17:50 2436

Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Jan. 4, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, its next generation anti-CTLA-4 fully human heavy-chain only antibody (HCAb), HBM4003, has completed the first dosing of first patient in two phase I tri...

2022-01-04 17:28 2491

Perfect combination of low power and high performance: Infineon introduces the new AIROC(TM) CYW20829 Bluetooth(R) LE system on chip

MUNICH, Jan. 4, 2022 /PRNewswire/ -- Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is launching the AIROC™ CYW20829 Bluetooth® LE system on chip (SoC). The AIROC CYW20829 Bluetooth LE SoC is a Bluetooth 5.3 core spec-compliant device for IoT, smart home and industrial applications. With the ...

2022-01-04 17:05 3171

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

FREMONT, Calif. and CAMBRIDGE, England, Jan. 4, 2022 /PRNewswire/ -- Alamar Biosciences  (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC...

2022-01-04 17:00 2858

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER

HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Today, Akeso (09926.HK) announces that Cadonilimab (PD-1/ CTLA-4 bi-specific antibody), the first-inclass novel immuno-oncology drug independently developed by the Company, combined with concurrent chemoradiotherapy obtained approval from the Center for Dru...

2022-01-04 10:00 2922

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH

* ASC43F was safe and well tolerated in healthy subjects with no clinically significant study drug related adverse events * Pharmacokinetic parameters of ASC41 and ASC42 from ASC43F are similar to those of ASC41 and ASC42 monotherapy * Phase I trial completed two months after the U.S. IND ap...

2022-01-04 08:30 4165